Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

SHE:000766 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	343.69	274.18	177.45	336.82	301.59	508.03
Trading Asset Securities	1.07	1.09	1.05	0.13	0.18	-
Cash & Short-Term Investments	344.76	275.27	178.49	336.95	301.77	508.03
Cash Growth	30.22%	54.22%	-47.03%	11.66%	-40.60%	75.58%
Accounts Receivable	540.72	526.27	520.31	470.42	397.13	458.94
Other Receivables	18.5	15.33	34.81	35.76	61.52	113.54
Receivables	559.22	541.6	555.12	506.18	458.65	572.49
Inventory	367.55	382.19	369.17	381.37	384.58	435.27
Other Current Assets	9.87	10.91	8.43	13.87	6.68	13.28
Total Current Assets	1,281	1,210	1,111	1,238	1,152	1,529
Property, Plant & Equipment	978.45	989.84	1,026	1,053	1,087	1,004
Long-Term Investments	1,848	1,848	1,986	1,989	1,989	1,990
Goodwill	1.9	1.9	1.9	1.9	1.91	1.91
Other Intangible Assets	178.53	184.96	201.67	216.61	233.4	250.06
Long-Term Deferred Tax Assets	31.73	31.73	13.6	14.69	19.33	46.82
Long-Term Deferred Charges	192.19	190.22	173.46	160.89	153.31	141.31
Other Long-Term Assets	24.08	26.94	5.85	10.47	5.37	13.14
Total Assets	4,537	4,484	4,519	4,685	4,641	4,977
Accounts Payable	198.22	182.31	191	221.79	150.59	187.94
Accrued Expenses	35.61	31.63	34.84	48.23	38.79	30.35
Short-Term Debt	249.72	194.75	130.16	25.04	40.06	125.16
Current Portion of Long-Term Debt	1,603	1,605	8.26	204.59	1,625	162.84
Current Portion of Leases	0.06	0.17	4.6	0.29	0.26	-
Current Income Taxes Payable	3.11	7.54	2.55	5.52	0.79	9.36
Current Unearned Revenue	18.32	14.66	11.66	39.79	11.5	25.73
Other Current Liabilities	86.59	121.26	189.42	126.6	160.79	222.16
Total Current Liabilities	2,195	2,157	572.49	671.86	2,028	763.53
Long-Term Debt	-	-	1,557	1,564	183.75	1,814
Long-Term Leases	3.08	2.83	2.14	4.44	3.98	-
Long-Term Unearned Revenue	63.95	65.53	64.75	71.83	78.9	85.37
Long-Term Deferred Tax Liabilities	2.36	2.99	4.36	4.94	7.3	8.9
Total Liabilities	2,264	2,228	2,201	2,317	2,301	2,672
Common Stock	966.49	966.49	966.49	966.49	966.49	966.49
Additional Paid-In Capital	3,579	3,579	3,579	3,642	3,642	3,642
Retained Earnings	-2,155	-2,172	-2,228	-2,272	-2,302	-2,337
Comprehensive Income & Other	-118.7	-118.7	-	-	-	-
Total Common Equity	2,272	2,255	2,318	2,337	2,307	2,271
Minority Interest	0.05	0.01	0.46	31.64	32.6	33.89
Shareholders' Equity	2,272	2,255	2,318	2,369	2,339	2,305
Total Liabilities & Equity	4,537	4,484	4,519	4,685	4,641	4,977
Total Debt	1,856	1,802	1,703	1,798	1,853	2,102
Net Cash (Debt)	-1,511	-1,527	-1,524	-1,461	-1,551	-1,594
Net Cash Per Share	-1.61	-1.62	-1.73	-1.45	-1.76	-1.64
Filing Date Shares Outstanding	966.49	966.49	966.49	966.49	966.49	966.49
Total Common Shares Outstanding	966.49	966.49	966.49	966.49	966.49	966.49
Working Capital	-913.59	-946.9	538.72	566.51	-875.86	765.54
Book Value Per Share	2.35	2.33	2.40	2.42	2.39	2.35
Tangible Book Value	2,092	2,069	2,114	2,118	2,071	2,019
Tangible Book Value Per Share	2.16	2.14	2.19	2.19	2.14	2.09
Buildings	688.61	688.35	687.85	685.07	682.42	557.14
Machinery	449.46	445.26	442.19	425.08	419.56	411.47
Construction In Progress	278.17	272.26	267.94	267.39	259.15	271.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.